Healthcare costs among patients with macular oedema associated with non-infectious uveitis: a US commercial payer’s perspective

OBJECTIVE: To describe patient characteristics and healthcare costs associated with uveitic macular oedema (UME) in US clinical practices from a commercial payer’s perspective. METHODS AND ANALYSIS: The IBM MarketScan Commercial Subset (1 October 2015–31 March 2020) was used to identify patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Hariprasad, Seenu M, Joseph, George, Gagnon-Sanschagrin, Patrick, Serra, Elizabeth, Bhattacharyya, Subrata, Bédard, Jérôme, Guérin, Annie, Albini, Thomas Arno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Uveitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587681/
https://www.ncbi.nlm.nih.gov/pubmed/34786486
http://dx.doi.org/10.1136/bmjophth-2021-000896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587681/
https://www.ncbi.nlm.nih.gov/pubmed/34786486
http://dx.doi.org/10.1136/bmjophth-2021-000896

Ejemplares similares